Avaglim

RSS
Withdrawn

This medicine's authorisation has been withdrawn

rosiglitazone / glimepiride
Medicine Human Withdrawn
  • Application under evaluation
  • CHMP opinion
  • European Commission decision

Overview

The marketing authorisation for Avaglim has been withdrawn for safety reasons following a decision by the European Commission.

Avaglim : EPAR - Summary for the public

English (EN) (511.34 KB - PDF)

First published: Last updated:
View

български (BG) (676.95 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

español (ES) (574.56 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

čeština (CS) (639.66 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

dansk (DA) (577.22 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

Deutsch (DE) (580.29 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

eesti keel (ET) (575.67 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

ελληνικά (EL) (688.24 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

français (FR) (578.92 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

italiano (IT) (579.68 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

latviešu valoda (LV) (646.64 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

lietuvių kalba (LT) (606.52 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

magyar (HU) (629.47 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

Malti (MT) (577.48 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

Nederlands (NL) (574.86 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

polski (PL) (639.54 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

português (PT) (574.95 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

română (RO) (607.15 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

slovenčina (SK) (635.29 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

slovenščina (SL) (630.33 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

Suomi (FI) (576.98 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

svenska (SV) (575.64 KB - PDF)

First published: 16/06/2008 Last updated: 17/01/2011
View

Product information

Avaglim : EPAR - Product Information

English (EN) (1.12 MB - PDF)

First published: Last updated:
View

български (BG) (2.77 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

español (ES) (1.33 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

čeština (CS) (1.83 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

dansk (DA) (1.27 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

Deutsch (DE) (1.23 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

eesti keel (ET) (1.12 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

ελληνικά (EL) (2.57 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

français (FR) (1.19 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

italiano (IT) (1.33 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

latviešu valoda (LV) (2.07 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

lietuvių kalba (LT) (1.57 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

magyar (HU) (1.75 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

Malti (MT) (1.84 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

Nederlands (NL) (2.12 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

polski (PL) (2.02 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

português (PT) (1.39 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

română (RO) (1.51 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

slovenčina (SK) (1.98 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

slovenščina (SL) (1.88 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

Suomi (FI) (1.15 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View

svenska (SV) (1.28 MB - PDF)

First published: 08/10/2008 Last updated: 17/01/2011
View
Latest procedure affecting product information:A20/0029
26/07/2011
icon globe

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

Avaglim : EPAR - All Authorised presentations

English (EN) (436.09 KB - PDF)

First published: Last updated:
View

български (BG) (522.48 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

español (ES) (436.31 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

čeština (CS) (475.2 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

dansk (DA) (436.62 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

Deutsch (DE) (435.54 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

eesti keel (ET) (436.51 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

ελληνικά (EL) (518.76 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

français (FR) (436.15 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

italiano (IT) (435.76 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

latviešu valoda (LV) (511.76 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

lietuvių kalba (LT) (504.68 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

magyar (HU) (550.99 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

Nederlands (NL) (429.54 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

polski (PL) (476.63 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

português (PT) (436.67 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

română (RO) (498.13 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

slovenčina (SK) (474.6 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

slovenščina (SL) (473.16 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

Suomi (FI) (435.82 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

svenska (SV) (436.71 KB - PDF)

First published: 12/04/2007 Last updated: 17/01/2011
View

Product details

Name of medicine
Avaglim
Active substance
  • rosiglitazone
  • glimepiride
International non-proprietary name (INN) or common name
  • rosiglitazone
  • glimepiride
Therapeutic area (MeSH)
Diabetes Mellitus, Type 2
Anatomical therapeutic chemical (ATC) code
A10BD04

Pharmacotherapeutic group

Drugs used in diabetes

Therapeutic indication

AVAGLIM is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control on optimal dosage of sulphonylurea monotherapy, and for whom metformin is inappropriate because of contraindication or intolerance.

Authorisation details

EMA product number
EMEA/H/C/000675
Marketing authorisation holder
SmithKline Beecham Ltd

980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom

Marketing authorisation issued
27/06/2006
Revision
11

Assessment history

Avaglim : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (442.61 KB - PDF)

First published: Last updated:
View

Avaglim-H-C-675-A-20-29: EPAR - Assessment Report

Adopted Reference Number: EMA/831387/2010

English (EN) (1.29 MB - PDF)

First published: Last updated:
View

Committee for Medicinal Products for Human Use post-authorisation summary of positive opinion for Avaglim on 24 January 2008

Reference Number: EMEA/CHMP/42762/2008

English (EN) (33.85 KB - PDF)

First published: Last updated:
View

Avaglim : EPAR - Scientific Discussion

English (EN) (1.04 MB - PDF)

First published: Last updated:
View

Avaglim : EPAR - Procedural steps taken before authorisation

English (EN) (508.29 KB - PDF)

First published: Last updated:
View

More information on Avaglim

This page was last updated on

Share this page

Back to top